The Medicines and Health products Regulatory Agency (MHRA) has issued a class three medicines recall notice for Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial).
Product manufacturer Accord has informed MHRA that it is recalling the batch as a precautionary measure following the observation of precipitation in the solution in the same batch marketed in another country-Malta.
No complaints or adverse reaction reports have been received by the company to date for the UK product, the medicine manufacturer has said.
Products details
Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) – PL 20075/0443.| Batch Number | Expiry Date | Pack Size | First Distributed |
| X21343 | 10/2021 | 1 x 5ml vial | 11/03/2019 |
The community pharmacists have been adviced to stop supplying the batch immediately to ensure the safety of the patients.
The healthcare professionals have also asked to quarantine all remaining stock of the medicine and return it to their respective supplier.
![Potential Side Effects of Mounjaro [What You Need to Know]](https://www.pharmacy.biz/media-library/image.jpg?id=54516976&width=1245&height=700&quality=90&coordinates=0%2C29%2C0%2C29)
